Literature DB >> 19215089

A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution.

Douglas S Auld1, Ya-Qin Zhang, Noel T Southall, Ganesha Rai, Marc Landsman, Jennifer MacLure, Daniel Langevin, Craig J Thomas, Christopher P Austin, James Inglese.   

Abstract

We measured the "druggability" of the ATP-dependent luciferase derived from the firefly Photuris pennsylvanica that was optimized using directed evolution (Ultra-Glo, Promega). Quantitative high-throughput screening (qHTS) was used to determine IC(50)s of 198899 samples against a formulation of Ultra-Glo luciferase (Kinase-Glo). We found that only 0.1% of the Kinase-Glo inhibitors showed an IC(50) < 10 microM compared to 0.9% found from a previous qHTS against the firefly luciferase from Photinus pyralis (lucPpy). Further, the maximum affinity identified in the lucPpy qHTS was 50 nM, while for Kinase-Glo this value increased to 600 nM. Compounds with interactions stretching outside the luciferin binding pocket were largely lost with Ultra-Glo luciferase. Therefore, Ultra-Glo luciferase will show less compound interference when used as an ATP sensor compared to lucPpy. This study demonstrates the power of large-scale quantitative analysis of structure-activity relationships (>100K compounds) in addressing important questions such as a target's druggability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19215089      PMCID: PMC3430137          DOI: 10.1021/jm8014525

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  41 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  Identification of kinase inhibitors by an ATP depletion method.

Authors:  Pirthipal Singh; Benedict J Harden; Benjamin J Lillywhite; Peter M Broad
Journal:  Assay Drug Dev Technol       Date:  2004-04       Impact factor: 1.738

3.  A rational approach to maximize success rate in target discovery.

Authors:  Martin Schneider
Journal:  Arch Pharm (Weinheim)       Date:  2004-12       Impact factor: 3.751

Review 4.  Transcreener: screening enzymes involved in covalent regulation.

Authors:  Robert G Lowery; Karen Kleman-Leyer
Journal:  Expert Opin Ther Targets       Date:  2006-02       Impact factor: 6.902

5.  The minimum significant ratio: a statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies.

Authors:  Brian J Eastwood; Mark W Farmen; Philip W Iversen; Trelia J Craft; Jeffrey K Smallwood; Kim E Garbison; Neil W Delapp; Gerald F Smith
Journal:  J Biomol Screen       Date:  2006-02-20

Review 6.  Application of scintillation proximity assay in drug discovery.

Authors:  Shaogui Wu; Bailing Liu
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

7.  Compound Management for Quantitative High-Throughput Screening.

Authors:  Adam Yasgar; Paul Shinn; Ajit Jadhav; Douglas Auld; Sam Michael; Wei Zheng; Christopher P Austin; James Inglese; Anton Simeonov
Journal:  JALA Charlottesv Va       Date:  2008-04

Review 8.  Luminogenic cytochrome P450 assays.

Authors:  James J Cali; Dongping Ma; Mary Sobol; Daniel J Simpson; Susan Frackman; Troy D Good; William J Daily; David Liu
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-08       Impact factor: 4.481

9.  Directed evolution of a fucosidase from a galactosidase by DNA shuffling and screening.

Authors:  J H Zhang; G Dawes; W P Stemmer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

10.  A specific mechanism for nonspecific activation in reporter-gene assays.

Authors:  Douglas S Auld; Natasha Thorne; Dac-Trung Nguyen; James Inglese
Journal:  ACS Chem Biol       Date:  2008-07-01       Impact factor: 5.100

View more
  24 in total

1.  Discovery, synthesis, and biological evaluation of novel SMN protein modulators.

Authors:  Jingbo Xiao; Juan J Marugan; Wei Zheng; Steve Titus; Noel Southall; Jonathan J Cherry; Matthew Evans; Elliot J Androphy; Christopher P Austin
Journal:  J Med Chem       Date:  2011-08-19       Impact factor: 7.446

2.  Comparison of bioluminescent kinase assays using substrate depletion and product formation.

Authors:  Cordelle Tanega; Min Shen; Bryan T Mott; Craig J Thomas; Ryan MacArthur; James Inglese; Douglas S Auld
Journal:  Assay Drug Dev Technol       Date:  2009-12       Impact factor: 1.738

Review 3.  Firefly luciferase: an adenylate-forming enzyme for multicatalytic functions.

Authors:  Satoshi Inouye
Journal:  Cell Mol Life Sci       Date:  2009-10-27       Impact factor: 9.261

4.  Comparison of luminescence ADP production assay and radiometric scintillation proximity assay for Cdc7 kinase.

Authors:  Toshimitsu Takagi; David Shum; Monika Parisi; Ruth E Santos; Constantin Radu; Paul Calder; Zahra Rizvi; Mark G Frattini; Hakim Djaballah
Journal:  Comb Chem High Throughput Screen       Date:  2011-09       Impact factor: 1.339

5.  Total Synthesis and Biological Studies of TMC-205 and Analogues as Anticancer Agents and Activators of SV40 Promoter.

Authors:  Yang Gao; Sami Osman; Kazunori Koide
Journal:  ACS Med Chem Lett       Date:  2014-06-23       Impact factor: 4.345

6.  Titration-based screening for evaluation of natural product extracts: identification of an aspulvinone family of luciferase inhibitors.

Authors:  Patricia G Cruz; Douglas S Auld; Pamela J Schultz; Scott Lovell; Kevin P Battaile; Ryan MacArthur; Min Shen; Giselle Tamayo-Castillo; James Inglese; David H Sherman
Journal:  Chem Biol       Date:  2011-11-23

7.  Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.

Authors:  Matthew B Boxer; Jian-kang Jiang; Matthew G Vander Heiden; Min Shen; Amanda P Skoumbourdis; Noel Southall; Henrike Veith; William Leister; Christopher P Austin; Hee Won Park; James Inglese; Lewis C Cantley; Douglas S Auld; Craig J Thomas
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

8.  A high-throughput 1,536-well luminescence assay for glutathione S-transferase activity.

Authors:  Adam Yasgar; John Shultz; Wenhui Zhou; Hui Wang; Fen Huang; Nancy Murphy; Erika L Abel; John DiGiovanni; James Inglese; Anton Simeonov
Journal:  Assay Drug Dev Technol       Date:  2010-04       Impact factor: 1.738

9.  A novel method for mining highly imbalanced high-throughput screening data in PubChem.

Authors:  Qingliang Li; Yanli Wang; Stephen H Bryant
Journal:  Bioinformatics       Date:  2009-10-13       Impact factor: 6.937

10.  Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries.

Authors:  Henrike Veith; Noel Southall; Ruili Huang; Tim James; Darren Fayne; Natalia Artemenko; Min Shen; James Inglese; Christopher P Austin; David G Lloyd; Douglas S Auld
Journal:  Nat Biotechnol       Date:  2009-10-25       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.